Cannara Biotech Inc. (TSXV: LOVE)
Canada
· Delayed Price · Currency is CAD
0.680
0.00 (0.00%)
Nov 21, 2024, 10:41 AM EST
Cannara Biotech Company Description
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada.
It also offers hemp-based CBD products. The company sells its products through wholesalers and online merchandisers.
In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Cannara Biotech Inc.
Country | Canada |
Founded | 2017 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
CEO | Zohar Krivorot |
Contact Details
Address: 333 Decarie Blvd. Saint-Laurent, British Columbia H4N 3M9 Canada | |
Phone | 514 543 4200 |
Website | cannara.ca |
Stock Details
Ticker Symbol | LOVE |
Exchange | TSX Venture Exchange |
Fiscal Year | September - August |
Reporting Currency | CAD |
ISIN Number | CA13765U1012 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Zohar Krivorot | Chief Executive Officer and Chairman |
Nicholas Sosiak C.A., CPA | Chief Financial Officer |
Avi Krivorot | Chief Technology Officer |
Anthony Manouk | Vice President of Compliance and GM |
Brian Sherman | General Counsel and Vice President Legal Affairs |
David Abitbol | Vice President of Marketing |
Scott Carroll | Vice President of Marketing and Sales |
France Landry | Vice President of Human Resources |
Julia Bouvet | Chief of Staff |
Etienne Ledoux | Executive Officer |